[
  {
    "ts": null,
    "headline": "Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore",
    "summary": "The market for obesity drugs may soon reach almost $100 billion.",
    "url": "https://finnhub.io/api/news?id=9172b19dfa0af646e8a5663adfbabdb6562fc7f3fa168459d70e17138e5bad78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770406500,
      "headline": "Eli Lilly vs Novo Nordisk: The 1 Figure Investors Shouldn't Ignore",
      "id": 138378135,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The market for obesity drugs may soon reach almost $100 billion.",
      "url": "https://finnhub.io/api/news?id=9172b19dfa0af646e8a5663adfbabdb6562fc7f3fa168459d70e17138e5bad78"
    }
  },
  {
    "ts": null,
    "headline": "Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential",
    "summary": "Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer options investors significant profit potential. Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer options investors significant profit pot",
    "url": "https://finnhub.io/api/news?id=0c3ce0dff43528822433b0cd4fc875a820a576c41b8943f60817b46acfa36e4b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770402901,
      "headline": "Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential",
      "id": 138379561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer options investors significant profit potential. Volatility returned to markets yesterday, triggering a tech rout. Among the unusually active options on Thursday were 278 calls and puts with Vol/OI ratios of 15 or higher. Among them, these 3 stocks offer options investors significant profit pot",
      "url": "https://finnhub.io/api/news?id=0c3ce0dff43528822433b0cd4fc875a820a576c41b8943f60817b46acfa36e4b"
    }
  },
  {
    "ts": null,
    "headline": "TrumpRx launches to slash drug prices for cash-paying US patients",
    "summary": "Medications, including obesity blockbusters Wegovy and Zepbound, are available on the site.",
    "url": "https://finnhub.io/api/news?id=d6e7dbc53480da50925cf5a9f28b71effdc7e2cc0e2bc791198412c3a166923e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770397082,
      "headline": "TrumpRx launches to slash drug prices for cash-paying US patients",
      "id": 138376806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Medications, including obesity blockbusters Wegovy and Zepbound, are available on the site.",
      "url": "https://finnhub.io/api/news?id=d6e7dbc53480da50925cf5a9f28b71effdc7e2cc0e2bc791198412c3a166923e"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo.",
    "summary": "Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.",
    "url": "https://finnhub.io/api/news?id=91898dadd1309937e53b1248661a65cb1ad95b5b5c686eada393d1d8d35f0cc3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770396720,
      "headline": "Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo.",
      "id": 138376807,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.",
      "url": "https://finnhub.io/api/news?id=91898dadd1309937e53b1248661a65cb1ad95b5b5c686eada393d1d8d35f0cc3"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Divided With S&P 500, Nasdaq Below Key Levels; Google, Amazon AI Spending Stuns: Weekly Review",
    "summary": "The stock market is divided, with the Nasdaq and S&P 500 breaking support but many sectors thriving. Google and Amazon AI spending stunned. Bitcoin plunged.",
    "url": "https://finnhub.io/api/news?id=c4f01e9c3b1e9347fe44c5aebf77b2ab32da7d2a01ca88e972e382c4373c8518",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770395265,
      "headline": "Stock Market Divided With S&P 500, Nasdaq Below Key Levels; Google, Amazon AI Spending Stuns: Weekly Review",
      "id": 138376762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The stock market is divided, with the Nasdaq and S&P 500 breaking support but many sectors thriving. Google and Amazon AI spending stunned. Bitcoin plunged.",
      "url": "https://finnhub.io/api/news?id=c4f01e9c3b1e9347fe44c5aebf77b2ab32da7d2a01ca88e972e382c4373c8518"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push",
    "summary": "PFE is betting on obesity and oncology in 2026, lining up 20 pivotal studies after $9B in 2025 M&A.",
    "url": "https://finnhub.io/api/news?id=be58eb620982563eb1157d3e8cc281873da85c5a40b01bbdcb619fd5233daad0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770393960,
      "headline": "Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push",
      "id": 138376809,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "PFE is betting on obesity and oncology in 2026, lining up 20 pivotal studies after $9B in 2025 M&A.",
      "url": "https://finnhub.io/api/news?id=be58eb620982563eb1157d3e8cc281873da85c5a40b01bbdcb619fd5233daad0"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Stock Jumps on Wave of Analysts Upgrade",
    "summary": "Eli Lilly Stock Surges Following Analyst Upgrades Across Portfolio",
    "url": "https://finnhub.io/api/news?id=478f3ef0cc41beff6b93a7be92144ea29f94d0c9021a21c42643b23e0eecaa3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770391791,
      "headline": "Eli Lilly Stock Jumps on Wave of Analysts Upgrade",
      "id": 138375421,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly Stock Surges Following Analyst Upgrades Across Portfolio",
      "url": "https://finnhub.io/api/news?id=478f3ef0cc41beff6b93a7be92144ea29f94d0c9021a21c42643b23e0eecaa3a"
    }
  },
  {
    "ts": null,
    "headline": "FTLS Increased Its Net Long Exposure, Especially In Technology",
    "summary": "The First Trust Long/Short Equity ETF invests almost exclusively in U.S.-domiciled companies. Here's what investors need to know about the FTLS ETF.",
    "url": "https://finnhub.io/api/news?id=aa3419a070029c7f1a7afd45c8e55fe71592d3c1c122d753de4114c249c1e223",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770389722,
      "headline": "FTLS Increased Its Net Long Exposure, Especially In Technology",
      "id": 138378215,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1384648610/image_1384648610.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The First Trust Long/Short Equity ETF invests almost exclusively in U.S.-domiciled companies. Here's what investors need to know about the FTLS ETF.",
      "url": "https://finnhub.io/api/news?id=aa3419a070029c7f1a7afd45c8e55fe71592d3c1c122d753de4114c249c1e223"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) is a Top-Ranked Growth Stock: Should You Buy?",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=8f560ecf7bce7a70aabd367f9ae4d8f0ad32dad0273a2e401d92946f1fd1598e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770389103,
      "headline": "Eli Lilly (LLY) is a Top-Ranked Growth Stock: Should You Buy?",
      "id": 138376810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=8f560ecf7bce7a70aabd367f9ae4d8f0ad32dad0273a2e401d92946f1fd1598e"
    }
  },
  {
    "ts": null,
    "headline": "NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill",
    "summary": "HIMS shakes up the weight loss market with a $49 compounded semaglutide pill, pressuring Novo Nordisk and Eli Lilly shares and sparking FDA and legal pushback.",
    "url": "https://finnhub.io/api/news?id=77ad211f8273e7b50ec44f34d37e21f66912eebaadee72f2c68b026ac562968d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770388020,
      "headline": "NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill",
      "id": 138376811,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "HIMS shakes up the weight loss market with a $49 compounded semaglutide pill, pressuring Novo Nordisk and Eli Lilly shares and sparking FDA and legal pushback.",
      "url": "https://finnhub.io/api/news?id=77ad211f8273e7b50ec44f34d37e21f66912eebaadee72f2c68b026ac562968d"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?",
    "summary": "INCY heads into Q4 earnings with strong Jakafi sales, rising royalties and multiple new launches contributing to revenues, setting the stage for a potential upside surprise.",
    "url": "https://finnhub.io/api/news?id=ac497b6025230b39f459722971c3dfd060cb89b1cc6c2f80d7940dd8585dbdcb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770384180,
      "headline": "Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?",
      "id": 138375422,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "INCY heads into Q4 earnings with strong Jakafi sales, rising royalties and multiple new launches contributing to revenues, setting the stage for a potential upside surprise.",
      "url": "https://finnhub.io/api/news?id=ac497b6025230b39f459722971c3dfd060cb89b1cc6c2f80d7940dd8585dbdcb"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk: The Selloff Is A Blessing In Disguise",
    "summary": "Novo Nordisk: The Selloff Is A Blessing In Disguise",
    "url": "https://finnhub.io/api/news?id=e838bc0cc2a01b7969d1c281d181da9723edcd6a6b306b476517323e69da0f1d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770383782,
      "headline": "Novo Nordisk: The Selloff Is A Blessing In Disguise",
      "id": 138377292,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e838bc0cc2a01b7969d1c281d181da9723edcd6a6b306b476517323e69da0f1d"
    }
  },
  {
    "ts": null,
    "headline": "China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.",
    "summary": "U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the rivalry?",
    "url": "https://finnhub.io/api/news?id=bf9fd4086cefba09a2c9616f9982f188dd4aa1ce3b7402fe5ec75ef2c5ac092b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770382821,
      "headline": "China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse.",
      "id": 138374408,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the rivalry?",
      "url": "https://finnhub.io/api/news?id=bf9fd4086cefba09a2c9616f9982f188dd4aa1ce3b7402fe5ec75ef2c5ac092b"
    }
  },
  {
    "ts": null,
    "headline": "Novo’s Stratospheric Rise Has Turned Into a $460 Billion Wipeout",
    "summary": "Novo shares have plunged 21%, hit first by guidance for a much steeper-than-expected decline in revenue, and then the launch by telehealth firm Hims & Hers Health Inc. of a cheaper copycat version of the Wegovy weight-loss pill.  The setbacks are just the latest to afflict the Danish company, which has seen years of dizzying gains wiped out since its market value peaked at $659 billion in June 2024.  The dramatic plunge has prompted some to question whether the foray into weight-loss treatments has been worth it.",
    "url": "https://finnhub.io/api/news?id=313deed0522bd971ee5f7ed191a2ee282355ebb33defffcab5c70d5d4b78d016",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770382370,
      "headline": "Novo’s Stratospheric Rise Has Turned Into a $460 Billion Wipeout",
      "id": 138374409,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Novo shares have plunged 21%, hit first by guidance for a much steeper-than-expected decline in revenue, and then the launch by telehealth firm Hims & Hers Health Inc. of a cheaper copycat version of the Wegovy weight-loss pill.  The setbacks are just the latest to afflict the Danish company, which has seen years of dizzying gains wiped out since its market value peaked at $659 billion in June 2024.  The dramatic plunge has prompted some to question whether the foray into weight-loss treatments has been worth it.",
      "url": "https://finnhub.io/api/news?id=313deed0522bd971ee5f7ed191a2ee282355ebb33defffcab5c70d5d4b78d016"
    }
  },
  {
    "ts": null,
    "headline": "Multiple Tailwinds Lifted Eli Lilly and Company (LLY) in Q4",
    "summary": "Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% (Institutional Shares) in the quarter, compared to a 11.92% gain for the Russell 3000 Health Care Index (benchmark) and a 2.40% gain for the Russell […]",
    "url": "https://finnhub.io/api/news?id=25a1a34820b296da8094cbefd784755df5f3a0a71d9efea3a409fa2ff785b3ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770382255,
      "headline": "Multiple Tailwinds Lifted Eli Lilly and Company (LLY) in Q4",
      "id": 138374410,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Health Care Fund”. A copy of the letter can be downloaded here. The fund rose 13.10% (Institutional Shares) in the quarter, compared to a 11.92% gain for the Russell 3000 Health Care Index (benchmark) and a 2.40% gain for the Russell […]",
      "url": "https://finnhub.io/api/news?id=25a1a34820b296da8094cbefd784755df5f3a0a71d9efea3a409fa2ff785b3ba"
    }
  },
  {
    "ts": null,
    "headline": "White House’s online service for drug sales debuts with limited impact on prices",
    "summary": "Select products from Pfizer, Eli Lilly and others will be sold at a discount, although the lower costs won’t be felt by many Americans whose medications are covered by insurance.",
    "url": "https://finnhub.io/api/news?id=9848a56c7fffd6e2975f109c5718388239a7e1122dfb3baf999ba965a90015d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770379680,
      "headline": "White House’s online service for drug sales debuts with limited impact on prices",
      "id": 138376812,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Select products from Pfizer, Eli Lilly and others will be sold at a discount, although the lower costs won’t be felt by many Americans whose medications are covered by insurance.",
      "url": "https://finnhub.io/api/news?id=9848a56c7fffd6e2975f109c5718388239a7e1122dfb3baf999ba965a90015d2"
    }
  },
  {
    "ts": null,
    "headline": "Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle.",
    "summary": "Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.",
    "url": "https://finnhub.io/api/news?id=79709532713fd563df40255bb5b9f2cf169dccaac7ad2c40932f8ef5f798982a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770379440,
      "headline": "Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle.",
      "id": 138374411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy knockoff.",
      "url": "https://finnhub.io/api/news?id=79709532713fd563df40255bb5b9f2cf169dccaac7ad2c40932f8ef5f798982a"
    }
  },
  {
    "ts": null,
    "headline": "Amazon Defies AI Fears With Huge Spending. Why It’s a Big Risk for Markets.",
    "summary": "The Bitcoin rout continues, one IPO pauses while three more move ahead, Hims & Hers offers knockoff Wegovy pill, and more news to start your day.",
    "url": "https://finnhub.io/api/news?id=8b156d1679158189005ff0656e1aa74a19ff7ee5ea33b928b8ad8da9052b8d93",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770378420,
      "headline": "Amazon Defies AI Fears With Huge Spending. Why It’s a Big Risk for Markets.",
      "id": 138373516,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The Bitcoin rout continues, one IPO pauses while three more move ahead, Hims & Hers offers knockoff Wegovy pill, and more news to start your day.",
      "url": "https://finnhub.io/api/news?id=8b156d1679158189005ff0656e1aa74a19ff7ee5ea33b928b8ad8da9052b8d93"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Today’s Movers: Amazon, Strategy, Novo Nordisk, Molina Healthcare, Strategy, Roblox, Hub Group, and More",
    "summary": "Amazon shares tumble after the tech and online retailing giant forecasts $200 billion in capital expenditures for 2026.",
    "url": "https://finnhub.io/api/news?id=c0252530b7df5877fc1cbb7896c869000128e515c7ec7ffb1e3df2551ee57901",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770378360,
      "headline": "These Stocks Are Today’s Movers: Amazon, Strategy, Novo Nordisk, Molina Healthcare, Strategy, Roblox, Hub Group, and More",
      "id": 138373517,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Amazon shares tumble after the tech and online retailing giant forecasts $200 billion in capital expenditures for 2026.",
      "url": "https://finnhub.io/api/news?id=c0252530b7df5877fc1cbb7896c869000128e515c7ec7ffb1e3df2551ee57901"
    }
  },
  {
    "ts": null,
    "headline": "US equity fund inflows ease as tech selloff weighs",
    "summary": "Feb 6 (Reuters) - U.S. equity funds witnessed an easing of demand in the week through February ​4 on caution over a selloff in ‌software stocks, although strong earnings from Eli Lilly and Super Micro ‌Computer offered some support.",
    "url": "https://finnhub.io/api/news?id=c6227c9773e4fd8202ae389179612a6dffb336fc51d5e9732791d61b1f3dcaa3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770373955,
      "headline": "US equity fund inflows ease as tech selloff weighs",
      "id": 138373573,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Feb 6 (Reuters) - U.S. equity funds witnessed an easing of demand in the week through February ​4 on caution over a selloff in ‌software stocks, although strong earnings from Eli Lilly and Super Micro ‌Computer offered some support.",
      "url": "https://finnhub.io/api/news?id=c6227c9773e4fd8202ae389179612a6dffb336fc51d5e9732791d61b1f3dcaa3"
    }
  },
  {
    "ts": null,
    "headline": "US President Launches TrumpRx.gov to Offer Branded Drugs at Discounted Prices",
    "summary": "US President Donald Trump introduced a platform called TrumpRx.gov on Thursday to lower drug prices,",
    "url": "https://finnhub.io/api/news?id=104799ba3490e9c0f0b165231d8fc9e3b74da11206a7cde9a86f3b9d9d25f837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770371881,
      "headline": "US President Launches TrumpRx.gov to Offer Branded Drugs at Discounted Prices",
      "id": 138373574,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US President Donald Trump introduced a platform called TrumpRx.gov on Thursday to lower drug prices,",
      "url": "https://finnhub.io/api/news?id=104799ba3490e9c0f0b165231d8fc9e3b74da11206a7cde9a86f3b9d9d25f837"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Friday",
    "summary": "Stocks look to rebound Friday after a turbulent, three-day slide.",
    "url": "https://finnhub.io/api/news?id=1c92102d9de6bc69f489dae30e3614b9d8882fdfba2efc5a9c23922ca2cc9fce",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770368540,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Friday",
      "id": 138376180,
      "image": "https://image.cnbcfm.com/api/v1/image/108231161-1764011282199-gettyimages-2247717735-US_STOCKS.jpeg?v=1764011302&w=1920&h=1080",
      "related": "LLY",
      "source": "CNBC",
      "summary": "Stocks look to rebound Friday after a turbulent, three-day slide. ",
      "url": "https://finnhub.io/api/news?id=1c92102d9de6bc69f489dae30e3614b9d8882fdfba2efc5a9c23922ca2cc9fce"
    }
  },
  {
    "ts": null,
    "headline": "Walmart Just Became the Newest Member of the Trillion-Dollar Club, and These 2 Non-AI Stocks May Be Next -- but There's a Catch",
    "summary": "Two standout companies from the same sector (no, not technology) have a clear path to follow in Walmart's footsteps.",
    "url": "https://finnhub.io/api/news?id=3cd31a787f5c5650208c71ea625c5461c540c7201c2db03a7217915b4b8f65ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770366360,
      "headline": "Walmart Just Became the Newest Member of the Trillion-Dollar Club, and These 2 Non-AI Stocks May Be Next -- but There's a Catch",
      "id": 138372911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Two standout companies from the same sector (no, not technology) have a clear path to follow in Walmart's footsteps.",
      "url": "https://finnhub.io/api/news?id=3cd31a787f5c5650208c71ea625c5461c540c7201c2db03a7217915b4b8f65ce"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Amazon, Reddit, Strategy, Molina, Strategy, Eli Lilly & more",
    "summary": "These are the stocks posting the largest moves in premarket trading.",
    "url": "https://finnhub.io/api/news?id=9fb589ad09858e81331f70e40504bf618137dfefb0af761390cf9b7cdbdec1df",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770362063,
      "headline": "Stocks making the biggest moves premarket: Amazon, Reddit, Strategy, Molina, Strategy, Eli Lilly & more",
      "id": 138376235,
      "image": "https://image.cnbcfm.com/api/v1/image/108262088-1770316900715-gettyimages-2258456949-20090101260130-99-336620.jpeg?v=1770379896&w=1920&h=1080",
      "related": "LLY",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in premarket trading. ",
      "url": "https://finnhub.io/api/news?id=9fb589ad09858e81331f70e40504bf618137dfefb0af761390cf9b7cdbdec1df"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers falls 8% after Novo's legal threat. Here's the latest",
    "summary": "Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was \"illegal\"",
    "url": "https://finnhub.io/api/news?id=0e8864700cde8f0e8a5786a1ec7da44486ff0b96b8f386c3a4f00bd2ca5cd8b9",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770360270,
      "headline": "Hims & Hers falls 8% after Novo's legal threat. Here's the latest",
      "id": 138376236,
      "image": "https://image.cnbcfm.com/api/v1/image/108099400-1738953241476-AP24142287309268.jpg?v=1738953354&w=1920&h=1080",
      "related": "LLY",
      "source": "CNBC",
      "summary": "Hims & Hers stock fall to a 12-month low after Novo said it's $49 Wegovy pill copy was \"illegal\"",
      "url": "https://finnhub.io/api/news?id=0e8864700cde8f0e8a5786a1ec7da44486ff0b96b8f386c3a4f00bd2ca5cd8b9"
    }
  },
  {
    "ts": null,
    "headline": "Walmart’s $1T valuation: A bet on high-income shoppers",
    "summary": "For years, the trillion-dollar club was an exclusive playground for tech giants, with their big spends and even bigger revenues. So when a healthcare company like Eli Lilly crossed that threshold and became the first in its sector to reach those numbers, it raised questions. And the answers ...",
    "url": "https://finnhub.io/api/news?id=9f4f394112083bb54e054ed43e2cd311fb5b6bfeb099b775c1bc15f4f103f471",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770352380,
      "headline": "Walmart’s $1T valuation: A bet on high-income shoppers",
      "id": 138371702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "For years, the trillion-dollar club was an exclusive playground for tech giants, with their big spends and even bigger revenues. So when a healthcare company like Eli Lilly crossed that threshold and became the first in its sector to reach those numbers, it raised questions. And the answers ...",
      "url": "https://finnhub.io/api/news?id=9f4f394112083bb54e054ed43e2cd311fb5b6bfeb099b775c1bc15f4f103f471"
    }
  },
  {
    "ts": null,
    "headline": "Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.",
    "summary": "There's another fight brewing around GLP-1 drugs -- this time on the delivery side.",
    "url": "https://finnhub.io/api/news?id=b78681fd5892162c0daac1e75d8cf3fd0f896085661c2c9b5afc2b270eb5f947",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770341700,
      "headline": "Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.",
      "id": 138370617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "There's another fight brewing around GLP-1 drugs -- this time on the delivery side.",
      "url": "https://finnhub.io/api/news?id=b78681fd5892162c0daac1e75d8cf3fd0f896085661c2c9b5afc2b270eb5f947"
    }
  },
  {
    "ts": null,
    "headline": "White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications",
    "summary": "Obesity and infertility treatments are among the first crop to appear with discounts on the government-run platform.",
    "url": "https://finnhub.io/api/news?id=024858d8a7a27ef44347f1ad601ae09e178d8716eee18e1c8475331eef50f5c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770341040,
      "headline": "White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications",
      "id": 138371226,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Obesity and infertility treatments are among the first crop to appear with discounts on the government-run platform.",
      "url": "https://finnhub.io/api/news?id=024858d8a7a27ef44347f1ad601ae09e178d8716eee18e1c8475331eef50f5c8"
    }
  },
  {
    "ts": null,
    "headline": "Trump Touts Drug Cost Savings as He Launches TrumpRx Website",
    "summary": "“Starting tonight, dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers through a new website, TrumpRx.gov,” Trump said at a White House event Thursday to hail the new effort.  The administration has touted its efforts to lower the cost of drugs, including by negotiating agreements with more than a dozen of the world’s largest pharmaceutical companies, including Eli Lilly & Co., Novo Nordisk A/S and Pfizer Inc., often in exchange for a reduction in threatened tariffs.",
    "url": "https://finnhub.io/api/news?id=c496ddde896a4d1d2328e83f71a269d47448c874a6e4923a97f8eebaa6565d44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770339419,
      "headline": "Trump Touts Drug Cost Savings as He Launches TrumpRx Website",
      "id": 138376813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "“Starting tonight, dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers through a new website, TrumpRx.gov,” Trump said at a White House event Thursday to hail the new effort.  The administration has touted its efforts to lower the cost of drugs, including by negotiating agreements with more than a dozen of the world’s largest pharmaceutical companies, including Eli Lilly & Co., Novo Nordisk A/S and Pfizer Inc., often in exchange for a reduction in threatened tariffs.",
      "url": "https://finnhub.io/api/news?id=c496ddde896a4d1d2328e83f71a269d47448c874a6e4923a97f8eebaa6565d44"
    }
  },
  {
    "ts": null,
    "headline": "Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem",
    "summary": "Hims & Hers Health launched a compounded version of Novo Nordisk's already popular weight-loss pill on Thursday. The FDA could be an issue.",
    "url": "https://finnhub.io/api/news?id=0229654d9f3be8f25c25fd7abbdda163a2596348545ac392fca3a9279ae00345",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770339161,
      "headline": "Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem",
      "id": 138370652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Hims & Hers Health launched a compounded version of Novo Nordisk's already popular weight-loss pill on Thursday. The FDA could be an issue.",
      "url": "https://finnhub.io/api/news?id=0229654d9f3be8f25c25fd7abbdda163a2596348545ac392fca3a9279ae00345"
    }
  }
]